Roche - M&A Summary and Business Overview

Life ScienceCompany

Roche M&A Summary

Roche has acquired 45 companies, including 10 in the last 5 years. A total of 10 acquisitions came from private equity firms. It has also divested 2 assets.

Roche’s largest acquisition to date was in 2009, when it acquired Genentech for $46.8B. Roche has acquired in 10 different US states, and 9 countries. The Company’s most targeted sectors include life science (70%) and medical products (12%).

Roche Business Overview

Where is Roche headquartered?

Roche is headquartered in Basel, Switzerland.

What is Roche’s revenue?

Roche disclosed revenue of 63,281M CHF for 2022 and 62,801M CHF for 2021.

How many employees does Roche have?

Roche has 100,920 employees.

What sector is Roche in?

Roche is a life science company.

When was Roche founded?

Roche was founded in 1896.

M&A Summary

  • M&A Total Activity44
    • M&A Buy Activity42
    • M&A Sell Activity2
  • Total Sectors Invested 8
  • Total Countries Invested 9
  • M&A Buy/Sell Connections 11
  • M&A Advisors 5

Roche

Roche Holding AG

Konzern-Hauptsitz Grenzacherstrasse124,
Basel, 4070
Switzerland,
+41 61 688 11 11
www.roche.com

Roche is a research-focused healthcare company focused on pharmaceuticals and diagnostics. Roche offers differentiated medicines in oncology, immunology, infectious diseases, ophthalmology and neuroscience. Roche is also the world leader in in vitro diagnostics and tissue-based cancer diagnostics, and a frontrunner in diabetes management. Roche was founded in 1896 and is based in Basel, Switzerland.


M&A Summary

Buy vs Sell

Year ≤ '19 '20 '21 '22 '23 '24 T
Buy (1.2/yr) # 36 2 1 1 2 - 42
vol $75.3B $428M $1.8B $250M $9.8B $87.6B
Sell (0.2/yr) # 1 - 1 - - - 2
  44

Most Recent M&A

Company Date Value Type
Carmot Therapeutics, Inc. 2023-12-04 2.7B USD Merger
Berkeley, California · www.carmot.us
Telavant Holdings, Inc. 2023-10-23 7.1B USD Divestiture
New York, New York · www.telavanttx.com
Good Therapeutics, Inc. 2022-09-07 250M USD Add-on Acquisition
Seattle, Washington · www.goodtherapeutics.com
Roche Holding - U.S. Ariosa Centralized Laboratory Prenatal Testing Business 2021-08-16 - Divestiture
Elmwood Park, New Jersey
GenMark Diagnostics, Inc. 2021-03-15 1.8B USD Merger
Carlsbad, California · www.genmarkdx.com
Inflazome Ltd. 2020-09-21 428M EUR Add-on Acquisition
Dublin, Ireland · www.inflazome.com
Stratos Genomics, Inc. 2020-05-22 - Add-on Acquisition
Seattle, Washington · www.stratosgenomics.com
Promedior, Inc. 2019-11-15 1.4B USD Merger
Lexington, Massachusetts · www.promedior.com
Foundation Medicine, Inc. 2019-06-19 5.3B USD Add-on Acquisition
Cambridge, Massachusetts · www.foundationmedicine.com
Spark Therapeutics, Inc. 2019-02-25 4.3B USD Add-on Acquisition
Philadelphia, Pennsylvania · www.sparktx.com
View All >>

M&A by Sector

Sector Buy # Value Sell # Value
Life Science 29 (69%) 82.1B (94%) 1 (50%) -
Medical Products 5 (12%) 5.2B (6%) - -
Healthcare Services 2 (5%) 366M (< 1%) - -
Information Technology 2 (5%) - - -
Chemicals 1 (2%) - 1 (50%) -
Internet Software and Services 1 (2%) - - -
Software 1 (2%) - - -
Test/Measurement Equipment 1 (2%) - - -
Total 42 $87.6B 2 -

By Geo

State/Country Buy Value Sell Value
United States 28 85.7B 1 -
  California 14 62.2B - -
  Massachusetts 5 7.4B - -
  Washington 2 250M - -
  Wisconsin 1 273M - -
  Pennsylvania 1 4.3B - -
  New York 1 7.1B - -
  Maryland 1 600M - -
  Georgia 1 - - -
  Connecticut 1 140M - -
  Arizona 1 3.4B - -
  New Jersey - - 1 -
Germany 4 176M - -
Switzerland 3 244M 1 -
United Kingdom 2 160M - -
Austria 1 - - -
Canada 1 145M - -
  Ontario 1 145M - -
Denmark 1 250M - -
France 1 530M - -
Ireland 1 428M - -
Domestic 3 (7%) 244M (< 1%) 1 (50%) -
Cross-border 39 (93%) 87.4B (100%) 1 (50%) -
Total 42 $87.6B 2 -

Top M&A Advisors

Financial Deals
Citigroup Investment Banking
7
Greenhill & Co., Inc.
1
Legal Deals
Davis Polk & Wardwell
7
Sidley
2
Foley & Lardner LLP
1

Deal Values

buy # Total
> $1B 10 $82.8B
$100M to $1B 17 $4.8B
< $100M 2 $29M
TOTAL $87.6B
Largest Genentech, Inc.
$46.8B (2009-03-12)

M&A Connections

Deals
Acquired from
Investor(s)
17%
7 (17%)
Strategic(s)
7%
3 (7%)
Divested to
Strategic(s)
50%
1 (50%)

 Subscribe to unlock this and 202,679
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.6K Private Equity Firms
  • 194K M&A Transactions
  • 198K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 75K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.